Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4561-4572

  Mariadason, J M ^a   Corner, G A ^a   Augenlicht, L H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CURCUMIN; NONSTEROID ANTIINFLAMMATORY AGENT; RNA; SHORT CHAIN FATTY ACID; SULINDAC; TRICHOSTATIN A;

ARTICLE; CANCER PREVENTION; CELL CYCLE; CELL MATURATION; COLON CANCER; COLON CARCINOGENESIS; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL;

ACETYLATION; ANTICARCINOGENIC AGENTS; BUTYRATES; CACO-2 CELLS; CELL CYCLE; CELL DIFFERENTIATION; COLON; COLONIC NEOPLASMS; CURCUMIN; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; KINETICS; MULTIGENE FAMILY; SIGNAL TRANSDUCTION; SULINDAC;

EID: 0034662614     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man
2. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
3. Short chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function
4. mt) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells
5. Short chain fatty acids in human large intestine, portal, hepatic and venous blood
6. Relationship of colonic luminal short-chain fatty acids and pH to in vivo cell proliferation in rats
7. Treatment of diversion colitis with short-chain-fatty acid irrigation
8. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats
9. Butyrate induced cell cycle arrest and apoptotic cascade in colonic carcinoma cells: Modulation of the B-catenin-Tcf pathway, and concordance with effects of sulindac and trichostatin, but not curcumin
10. Short chain fatty acid metabolism, apoptosis and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa
11. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer
12. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line
13. n-butyrate causes histone modification in HeLa and Friend erythroleukemia cells
14. The effect of sodium butyrate on histone modification
15. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats
16. Butyrate selectively inhibits the metallothionine gene in teratocarcinoma cells and induces hypersensitivity to metal induction
17. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate
18. Transcriptional upregulation of γ-globin by phenylbutyrate and analogous aromatic fatty acids
19. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate
20. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro
21. Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer
22. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer
23. Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells
24. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
25. Serial analysis of gene expression
26. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
27. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization
28. Gene expression profiles in normal and cancer cells
29. The transcriptional program in the response of human fibroblasts to serum
30. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin
31. Sulindac for polyposis of the colon
32. Sulindac polyposis of the colon
33. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
34. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
35. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
36. Effect of dietary curcumin and ascorbyl palmitate on azoxymethane-induced colonic epithelial cell proliferation and focal areas of dysplasia
37. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice
38. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt formation in the rat colon
39. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
40. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats
41. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer
42. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
43. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
44. Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
45. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
46. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway
47. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway
48. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation
49. Making and reading microarrays
50. Cluster analysis and display of genome-wide expression patterns
51. The expression of three abundance classes of messenger RNA in mouse tissues
52. Comparison of polysomal and nuclear poly(A)-containing RNA populations from normal rat liver and Novikoff hepatoma
53. Post-transcriptional regulation of messenger abundance in rat liver and hepatoma
54. Activation of cellular genes by avian RNA tumor viruses
55. Manifold expression of new cellular genes in human lymphoid neoplasia
56. Molecular cloning of gene sequences regulated by platelet-derived growth factor
57. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy
58. Rectal cancer after prolonged sulindac chemoprevention
59. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp
60. Cloning and screening of sequences expressed in a mouse colon tumor
61. Gene structure and expression in colon cancer
62. A public database for gene expression in human cancers
63. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
64. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
65. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling